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Establishing realistic exposure scenarios is critical for cytotoxic investigation of silver (Ag) 
nanoparticles in the gastrointestinal tract. This study investigated the potential interaction with and 
effect of biofluid components, namely cholic acid, deoxycholic acid and ursodeoxycholic acid, on 
AgNP toxicity. Two cell lines corresponding to organs related to the biofluid components were 
employed. These were HepG-2 a hepatocellular carcinoma derived from liver tissue and Hep2 an 
epithelial cell line. Physiochemical and cytotoxic screening was performed and the ability of 
biofluid components to modify AgNP cytotoxicity was explored. No alteration to the 
physiochemical characteristics of AgNP by biofluid components was demonstrated. However, 
biofluid component addition resulted in alteration of AgNP toxicity. Greater ROS induction was 
noted in the presence of CA and DCA. UDCA demonstrated no modification of toxicity in HEpG-
2 cells however significant modification was noted in Hep2 cells. It is concluded that biofluid 
components can modify AgNP toxicity but this is dependent on the biofluid component itself and 
the location where it acts. 
 
Short Abstract 
Silver nanoparticle (AgNP) interaction with biofluids upon entry to the body is important for 
accurate toxicological investigation. A number of toxicological tests were performed and 
demonstrated modification of AgNP toxicity by the chosen biofluid components cholic acid, 
deoxycholic acid and ursodeoxycholic acid. It is concluded that the influence on AgNP toxicity by 
biofluid components is dependent on the biofluid component itself and the location where it acts. 
 
Introduction 
Nanotechnology has been described as a new frontier in science and technology with many 
different applications in fields including textiles, electronics, medicine, cosmetics and food (Sozar 
& Kokini, 2009; Bouwmeester et al, 2009). Silver (AgNP) nanoparticles in particular are 
becoming the material of choice for incorporation into consumer goods mainly due to their 
antimicrobial properties (Choi et al, 2008). Compared to bulk silver, nanosilver displays different 
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physiochemical properties due to its size and increased surface area including increased photonics 
and catalytic properties as well as enhanced antimicrobial activity (Choi et al, 2008; Poda et al, 
2011; Zhai et al, 2006). 
When considering nanoparticle exposure it is important to take into account not only the route of 
entry to the body but also the various biological systems, biofluids and surfactants they will 
encounter. Indeed as a result of the potential interaction with the various components of bio-fluids, 
nanoparticles may be affected ultimately changing how they interact with cells and the responses 
they evoke. 
With the ever increasing use of nanoparticles in food products and with new EU legislation 
enforcing that all forms of engineered nanoparticles present in food must be stated on food 
packaging, “nano-labeling” coming into effect in December 2014, it is now more crucial than ever 
that the interaction between nanoparticles and living systems is thoroughly investigated (Nano and 
other Emerging Technologies Blog, 2013). In particular, the potential toxic effect of nanoparticles 
to the gastrointestinal tract and their interactions with various biofluids associated with this system 
must be determined. 
The gastrointestinal tract has been noted as a major area of AgNP deposition coupled with 
pathological responses. A number of studies have demonstrated damaged microvilli and intestinal 
glands, abnormal pigmentation and an increase in intestinal goblet cells following oral 
administration of AgNP in rats (Hadrup & Lam, 2014; Shahare & Yashpal, 2013; Jeong et al, 
2010; Kim et al, 2010). The liver in particular is an important site of nanoparticle deposition 
following oral ingestion with reports of high concentrations of AgNP reported in mice 24 hours 
after exposure. Inhalation also provides a route to the liver. Mucocilliary clearance of nanoparticles 
can result in entry to the GI tract and deposition in the liver. Accumulation of AgNP can lead to 
liver toxicity including bile duct hyperplasia and inflammation (Kim et al, 2008; Nemmar et al, 
2002). The liver has also been identified as a one of the main pathways involved in nanoparticle 
excretion. Hepato-biliary secretion is believed to be a main route of intestinal secretion of 
nanoparticles with evidence of gold and polystyrene nanoparticle excretion by this route. 
Accumulation of nanoparticles within bile canaliculi is suggestive of the important role of bile in 
the intestinal secretion and elimination of nanoparticles in faeces (Zhao et al, 2014; Johnston et al, 
2010; Semmler-Behnke et al, 2008).  
 
A biofluid is any fluid originating from within the body that can be excreted, secreted, obtained by 
a needle or can develop due to a pathological process and ranges from blood to bile and breast 
milk to cyst fluid (Medicinenet). It has been shown that certain biofluids and surfactants can aid 
the processing of nanoparticles and can isolate nanoparticles from larger agglomerates by coating 
the particle or modifying its surface chemistry (Herzog et al, 2009). Interactions with various 
surfactants including biological surfactants and fluids can result in adsorption of a variety of 
different molecules and proteins onto the surface of nanoparticles. As a result many studies have 
shown that this “coating” can affect how a nanoparticle interacts with the biological environment. 
These affects range from changes in the particle itself such as ion release and changes in 
morphology to the responses it induces and where it is trafficked within the body (Herzog et al, 
2009; Mwilu et al, 2013; Ehrenberg et al, 2009; Wang et al, 2013; Misra et al, 2012; Aggarwal et 
al, 2009). It is this ability of biofluids to interact and process foreign bodies in the human body 
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that make them integral to the defence systems of the body. In this study three components of bile 
were chosen and are referred to as biofluid components throughout as they were studied 
individually.  The biofluid components employed were cholic acid (CA), deoxycholic acid (DCA) 
and ursodeoxycholic acid (UDCA).  
Bile salts are organic solutes synthesized from cholesterol by hepatocytes (Kumar & Bohidar, 
2010; Perez & Briz, 2009). Cholic acid is one of the major primary bile acids in the liver and is 
synthesized from cholesterol and constitutes about 30-40% of bile acids (Debruyne et al, 2001). 
Formation of these bile acids is important in cholesterol homeostasis. Deoxycholic acid is a 
secondary bile acid and constitutes roughly 10-40% of total bile (Marcus & Heaton, 1988). DCA 
has also been demonstrated to promote colonic epithelium proliferation (Deschner et al, 1981; 
Ochsenkuhn et al, 1999). UDCA is a secondary bile acid comprising 3% of total bile acids (Perez 
& Briz, 2009). Despite its low abundance it has been shown to have direct antioxidant properties 
especially against hydroxyl radicals and can also prevent the retention of certain toxic hydrophobic 
bile acids. UDCA has also a number of therapeutic applications including dissolving gall stones 
and as an alternative therapy for hepatitis C patients in place of interferon therapy (Arisawa et al, 
2009; Lapenna et al, 2002). This particular bile acid has also shown promise as a potential targeted 
therapy for colorectal cancer (Debruyne et al, 2001).  
This study aims to demonstrate if biofluid components can mediate nanoparticle toxicity. Their 
incorporation may enhance or reduce cytological effects and has often been overlooked in 
cytotoxicity screening, which will be addressed here. The European Union define a nanomaterial 
as “A natural, incidental or manufactured material containing particles in an unbound state or as 
an aggregate or as an agglomerate, and where for 50%  or more of the particles in the number 
size distribution, one or more external dimensions is in the range 1-100nm” (European 
Commission, 2011). In keeping with this definition it is important to investigate the interaction of 
biofluid components with nanoparticles to determine if the chemistry is affected resulting in a 
change in size distribution or agglomerative state potential causing the nanoparticles to fall outside 
the criteria of a nanomaterial as per the EU definition.  The effect of biofluid components on the 
size distribution and agglomerative state of AgNP was investigated using dynamic light scattering 
analysis and zeta potential analysis. The cell lines chosen were HepG-2 a hepatocellular carcinoma 
(liver) and Hep2 an epithelial cell line employed as a control.  A cytotoxic profile of AgNP was 
carried out using the standard cytotoxic assays 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) and Alamar Blue (AB) viability assays. A 2’, 7’-
dichlorofluorescin diacetate (DCFH-DA) plate assay was used to detect any intracellular ROS 
generations in response to AgNP exposure.  
 
Materials and Methods 
Test materials and reagents 
Polyvinylpyrrolidone (PVP) coated silver (Ag) nanopowder of < 100nm Catalogue No: 758329, 
was purchased from Sigma-Aldrich Ltd (Dublin, Ireland). PVP coating was confirmed by XRD 
analysis. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) Catalogue No: 
M5655 and 2’,7’- dichlorofluorescin diacetate (DCFH-DA) Catalogue No: D6883 as well as cell 
culture media, supplements and trypsinisation solution were all purchased form Sigma-Aldrich 
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Ltd (Dublin, Ireland). Alamar blue (AB) was purchased from Biosciences (Dublin, Ireland). 
UDCA, CA and DCA were purchased from Sigma-Aldrich (Dublin, Ireland). 
 
Cell culture 
HepG-2 cells (ATCC: HB-8065) an immortalized hepatocellular carcinoma cell line and Hep2 
(ATCC: CCL-23) a cell line of laryngeal origin were employed in this study. HepG-2 cells were 
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) with 2mM L-glutamine, sodium 
pyruvate and supplemented with 10% foetal bovine serum (FBS) at 37°C in humidified 5% CO2. 
Hep2 cells were cultured in RPMI-1640 medium supplemented with 10% FBS, 45 IU/ml penicillin 
and 45 IU/ml streptomycin at 37°C in humidified 5% CO2. All cell culture media including FBS 
other reagents and supplements are from Gibco purchased through Biosciences (Dublin, Ireland). 
 
Characterization of nanoparticles 
Prior to the cytotoxicity testing, pristine AgNP and AgNP in various dispersions in the presence 
of each biofluid component were characterized. The suspensions of AgNP were prepared in 
deionised water (dH2O), DMEM and RPMI media using a bath-sonicator for 20 minutes (Degussa-
Ney ULTRAsonik 57X 50/60 Hz, California, USA) prior to size and zeta potential analysis. 
Dynamic light scattering and zeta potential measurements were performed with the aid of a 
Malvern ZetaSizer Nano ZS (Malvern Instruments, Worcestershire, UK) operating with version 
5.10 of the systems Dispersion Technology Software (DTS Nano). For size measurement 
DTS0012 disposable sizing cuvettes were used. The samples were equilibrated at 25°C for 2 
minutes before each measurement. For zeta potential analysis, DTS1060T clear disposable zeta 
cells were used and measurements were performed with the automatic model setting, using a 
voltage of five to minimize artefacts and charring of media proteins during analysis.  
Scanning Electron Microscopy (SEM) was also employed to estimate nanoparticle size from the 
images produced by this technique. A Hitachi SU 6600 FESEM instrument was used to obtain 
images of the AgNps. First the SEM was calibrated with Au on Carbon standard provided by Agar 
Scientific (Essex, UK). Samples were prepared by dispersing particles in ethanol by sonication 
750 watts Ultrasonic Processor tip (Branson Ultrasonics, Ultra sonic processor VCX-750W) at 
40% amplitude for a total of 45 seconds. Samples were spin coated onto pure silicon wafer which 
had been thoroughly cleaned by sonication in acetone for 30 minutes followed by boiling in 
propanol for 30 minutes. Silicon wafers were then left to air dry in a dust free environment and the 
nanoparticle sample was then spin coated onto wafers 24 hours prior to measurement. 
The specific surface area of AgNP was established with a Micrometrics GEMINI BET. BET 
sample holders were filled with a known mass of powdered nanoparticles and measured. The 
sample was degassed for two hours at room temperature with nitrogen gas prior to analysis. 
Nitrogen gas was used as the absorptive gas and a multipoint method was used in the estimation 




The AB and MTT assays were performed for assessment of cytotoxicity of AgNP to the three cell 
lines. The test used a range of eight concentrations of AgNP (3.91-500µg/ml) in which effects 
were likely to occur, this in turn allowed inhibitory concentration (IC50) to be calculated. In all 
cases results were compared to an unexposed control (cells in culture media only), eliminating any 
dependence of the cell line exposures on well type, seeding efficiency and numbers, exposure 
times and volumes. A stock suspension of AgNP was prepared aseptically from which different 
concentrations of nanoparticles were prepared in the respective HepG-2 and Hep2 cell media 
followed by sonication (Branson Ultrasonics, Ultra sonic processor VCX-750W, maximum 
amplification 40%). As a positive control 10% DMSO was prepared in the respective media. For 
cytotoxic analysis of nanoparticles in the presence of biofluid components, a range finding 
experiment was performed to determine concentration of interest for the definitive experiment. A 
stock solution of this test concentration was prepared for each biofluid component, UDCA, CA 
and DCA, in the appropriate cell media. A dose finding experiment for each bile acid was 
performed in the respective cell lines to determine a working concentration for cytotoxic studies. 
The working concentration was noted to have no cytotoxic effect when exposed to cells alone. 
Based on the dose finding experiments and previous studies concentrations of 50µM, 1mM and 
0.125mM were prepared for UDCA, CA and DCA respectively and a concentration of 2.2 x 10-
7M UDCA was prepared for Hep2 cell line (Arisawa et al, 2009). Using this solution of each 
biofluid component, a stock dispersion of AgNP was prepared aseptically from which a range of 
nanoparticle concentrations was prepared. For all assays and exposure scenarios fresh nanoparticle 
suspensions were prepared for each experiment. 
 
Alamar Blue assay 
For the AB assay, cells were seeded in 96 well microtitre plates (Nunc, Denmark) at a density of 
1 x 10⁵, 5 x 104, 4 x 104 and 3 x 104 cells/ml for 24, 48, 72 and 96 hour exposures respectively in 
100µl of cell culture media containing 10% FBS. At least three independent experiments were 
conducted with six replicate wells employed per concentration per plate in each independent 
experiment. After 24 hours of cell attachment, plates were washed with 100µl/well PBS and treated 
with increasing concentrations of AgNP prepared in media for 24, 48, 72 and 96 hours. All 
incubations were performed at 37°C in a 5% CO2 humidified incubator. The assay was performed 
according to manufacturer’s instructions. Briefly, control media and test exposures were removed, 
cells were rinsed with 100µl PBS and 100µl of AB solution (5% [v/v] solution of AB) prepared in 
fresh media with no added supplements were added to each well. After 3 hour incubation AB 
fluorescence was measured at excitation and emission wavelength of 531nm and 595nm 
respectively in TECAN GENios (Grodig, Austria). Wells containing AB solution and media only 
were used as blanks. For this assay the mean fluorescence units for six replicate cultures were 
calculated for each exposure treatment. Acellular studies were performed with test particles and 







As with the AB assay a parallel set of three plates were set up for the MTT assay, seeded and 
exposed as previously described. After the same exposure times as AB assay, 24, 48, 72 and 96 
hours, test medium was removed. Cells were washed with 100µl PBS and 100µl of freshly 
prepared MTT solution (5mg/ml MTT in media {without supplements}) was added to each well. 
After 3 hour incubation the solution was removed, cells were rinsed 100µl PBS and 100µl MTT 
fixative (DMSO) was added to each well. Plates were shaken at 240rpm for 10 minutes. Following 
this step the supernatant was removed and transferred to a new 96 well plate for analysis as it has 
been observed that sedimentation of AgNP on the bottom of wells interferes with absorbance 
readings producing higher values. Absorbance was read at 595nm in TECAN GENios (Grodig, 
Austria). Acellular studies were performed with test particles and the AB dye to confirm no 
interference of the particle with dye reduction (Gupta Mukherjee et al, 2012). 
 
Reactive Oxygen Species (ROS) studies 
Intracellular oxidative stress was quantified using a 2’, 7’-dichlorofluorescin diacetate (DCFH-
DA) plate assay to detect intracellular hydroperoxides and probe for a wide range of ROS. 
Confluent cells were trypsinized and seeded at a density of 1 x10⁵ cells/ml prepared in media, onto 
96 well black bottomed plates (Nunc, Denmark) and allowed to attach for 24 hours. Six 
independent experiments were performed with six replicate wells for negative control, positive 
control and test concentrations on each plate. A working stock of 20µM DCFH-DA in PBS was 
prepared and all test concentrations, positive and unexposed negative controls were prepared in 
this working stock and exposed to cells. The negative control consisted of 20µM DCFH-DA in 
PBS only, the positive control was 5µM hydrogen peroxide (H2O2) prepared in DCFH-DA/PBS 
working stock and the AgNP test concentrations (3.91-500µg/ml) together with the AgNP-biofluid 
component test concentrations were prepared in the DCFH-DA/PBS working stock. Prior to 
cellular testing, acellular studies were performed with the test particles and the DCF dye at all test 
scenarios to confirm no reduction of the dye due to AgNP interference. No reduction of DCFH-
DA by AgNP was noted (Gupta Mukherjee et al, 2012). 
After 24 hours of attachment, the media was removed and wells were washed with PBS, 
100µl/well. Cells were then treated with 100µl of positive control, negative control and test 
concentrations and plates are incubated for 15min, 30 min, 1hr, 2hr, 3hr, 4hr, 5hr and 6hr. The rate 
of intracellular ROS production was monitored at each time point by the emission of DCFH-DA 
at 529nm by excitation at 504nm at the various time points (plates were re-incubated after each 




Confluent cells were trypsinized and at a concentration of 1 x 105 cells/ml, 100µl of cell suspension 
were seeded onto 35mm glass bottom dishes (MatTek Corporation, Ashland, MA, USA). Glass 
dishes were incubated for 1 hour. Following incubation 1ml of cell culture media was added to 
cell suspensions. Dishes were re-incubated and allowed to attach for 24 hours. A working stock of 
10µM CM-H2DCFDA (Molecular Probes- Invitrogen, California, USA) was prepared in DMSO.  
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A stock suspension of AgNP was prepared aseptically from which different concentrations of 
nanoparticles were prepared in cell media followed by bath-sonication (Degussa-Ney 
ULTRAsonik 57X, California, USA).  As a positive control, 10% DMSO was prepared in the 
respective media. The negative control consisted of cell culture media only. 
After 24 hours of attachment, media was removed and glass dishes were washed with PBS 
1ml/dish.  Cells were treated with 100µl of CM-H2DCFDA and incubated for 30 minutes. After 
incubation, dishes were washed in PBS 1ml/dish. 1ml test concentrations, negative and positive 
controls were added to dishes and incubated for 1 hour. After incubation dishes were washed in 
PBS 1ml/dish and imaged immediately. Images were taken on a Zeiss 510 LSM confocal 
microscope with an external argon ion laser source of 488nm excitation and using a bandpass filter 
of 505-530nm to detect the fluorescent DCF dye. 
 
Statistical analysis 
At least three independent experiments were performed for each cytotoxicity endpoint. Results for 
each assay were expressed as a percentage of unexposed control ± standard deviation with control 
values set as 100%. Statistically significant differences between samples and their respective 
controls were calculated using the statistical analysis package InStat. Statistically significant 
differences were set at p<0.05. Normality of data was confirmed with Q-Q percentile plots and 
Kolmogorov-Smirnov tests. Equality of variances was evaluated using Levène tests. One-way 
analysis of variances (ANOVA) followed by Dunnett’s multiple comparison tests were carried out 
for normally distributed samples with homogeneous variances. Non-parametric tests, namely 
Kruskal-Wallis followed by Mann-Whitney-u-tests were applied to samples without normal 
distribution and/or inhomogeneous variances. Cytotoxicity data (where appropriate) was fitted to 
a sigmoidal curve and a four parameter logistic model used to calculate the Inhibitory 
Concentration (IC50) values. The IC50 value refers to a concentration of a compound where a 50% 
effect is observed in this case a reduction in cell viability. IC50 values were reported as ±95% 
confidence intervals. IC50 values were estimated using XLfit3™, a curve fitting add on for 





The methods of particle characterization employed to determine the relative size of AgNP as 
purchased and in various suspensions were Scanning Electron Microscopy and Dynamic Light 
Scattering. Figure 1 shows SEM analysis of a dilute sample of AgNP. This sizing method was 
performed on pristine particles as purchased from Sigma-Aldrich (Catalogue No: 758329). In order 
to obtain an accurate size reading a sample number of particles (eg. 100 particles) were chosen and 
their average size determined. SEM revealed spherical particles with an average particle size of 
30nm. This method reflects the physical particle diameter of the pristine particles as purchased. In 
a study published by Gupta Mukherjee et al (2012) SEM analysis determined a diameter of <50nm 
 8 
 
for the same Sigma-Aldrich AgNP employing the same preparation method for SEM analysis as 
this study (Gupta Mukherjee et al, 2012). While this method of particle sizing provides useful 
information on the pristine AgNP, it does not represent how particles will be presented to 
biological systems upon entering the body and how the various biofluids they come into contact 
with may affect them. While SEM analysis provides a fast analysis of nanoparticles with a simple 
sample preparation, analysis of biological samples by this method requires fixation and any change 
in nanoparticle size due to interaction with biological material cannot be monitored by this method. 
DLS analysis will allow monitoring of the system AgNP are suspended in and provide data on 
particle hydrodynamic radius and any change that occurs due to the presence of certain biological 
material, in this case protein components of cell culture media and biofluid components. 
 
DLS size measurements were performed on pristine AgNP suspended in dH2O and cell culture 
media with and without the addition of the tested biofluid components to the media. Three 
concentrations of AgNP were chosen for DLS analysis the highest concentration in which particles 
were dispersed, 62.5µg/ml, a low concentration where particles were still visible when dispersed, 
3.9µg/ml and a concentration in between 15.6µg/ml. DLS data from this study is illustrated in 
figure 2 (a)-(d). When suspended in a biological media the various proteins within that media can 
associate with any nanoparticles present and it is postulated that this protein coating can determine 
the response of biological systems rather than the particles themselves (Lynch et al, 2007). It can 
be assumed that any protein association that occurs in the nanoparticle dispersions presented here 
may impact the hydrodynamic radius of particles and cause possible agglomeration. 
 
The concentration of 15.6µg/ml was chosen as a representative concentration between a high and 
low concentration of AgNP, it is also a concentration at which an effect on cells is observed as 
will be discussed later. From DLS analysis, particle size in dH2O was determined to be 34nm ±SD 
3.5nm. A shift in hydrodynamic radius was observed in preparations of AgNP in RPMI. Dispersed 
in RPMI alone there are two clear peaks observed one representing RPMI itself and the other at 
approximately 40nm representing AgNP. Upon addition of UDCA to the dispersion it does not 
appear to have an effect on the hydrodynamic radius. The two peaks are still observed with only a 
slight increase in size distribution. This variation may be explained by a shift in the plane of shear 
upon addition of UDCA as UV-Vis spectroscopic analysis demonstrated no significant interaction 
of AgNP with the cell culture media components. In the presence of DMEM there is shift in the 
distribution of AgNP compared to their dispersion in dH2O. The first peak remains relatively 
unchanged apart from a reduced number of particles falling within this size range. The second 
wider peak demonstrates the greatest change with the majority of particles falling within this size 
range which has shifted to below 100nm. However upon addition of UDCA, CA and DCA (figure 
(b) – (d)) significant changes are noted with only one peak between 1-10nm observed which was 
attributed to DMEM. Ursodeoxycholic acid, cholic acid and deoxycholic acid have a large size 
distribution (greater than 200nm) and may result in the formation of large agglomerates with 
nanoparticles, causing them to precipitate out at an elevated rate preventing their detection by DLS 
analysis resulting in the detection of DMEM only. Further investigation is required into why these 
particular dispersions of AgNP and biofluid components cannot be detected by DLS analysis and 
how this will ultimately affect their toxicological testing.  
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The UV-Vis absorption analysis of the different preparations of AgNP and cell culture media 
demonstrated no significant changes to the spectra. No alterations in spectra were noted suggesting 
that secondary toxicity caused by nutrient depletion would be unlikely.  
Zeta potential analysis, illustrated in Table 1, was performed using the same sample preparations 
as for sizing analysis. Typically values above 30mV or below -30mV indicate stability of the 
overall system. Zeta potential analysis of AgNP dispersed in dH2O showed instability of particles 
at all test concentrations which is unexpected as the particles purchased are PVP coated. When the 
particles were dispersed in the test media differences were noted and the AgNP in RPMI 
demonstrated stable results, whereas interestingly dispersion of AgNP in DMEM was revealed to 
be unstable. Upon the addition of the bile components CA, DCA and UDCA however the system 
was also found to be unstable. The large values noted when particles are dispersed in media and 
media with biofluid components would suggest a tendency to repel each other and as such reduce 
the likelihood of agglomeration (Xia et al, 2006). It can be assumed from the data that the addition 
of biofluid components does not modify the overall stability of the system. 
BET analysis was also employed to determine surface area of pristine powder and yielded a surface 
area of 2.3 ± 0.1 m2/g. 
 
Cytotoxicity Testing 
Viability assays were performed to determine the effect of AgNP exposure to HepG-2 and Hep2 
cell lines. The ability of the biofluid components UDCA, CA and DCA to modify the toxic 
response of AgNP was also evaluated. Cytotoxicity data for AgNP exposure in the HepG-2 and 
Hep2 cell lines are presented in table 2. The results of the MTT assay are presented for each cell 
line in the presence and absence of the respective biofluid component. Both MTT and AB assays 
were performed for each cell line. Results for AB assay are not shown. 
 
 
Cytotoxic evaluation HepG-2 cell line to AgNP exposure alone and in the presence of UDCA, 
CA and DCA 
 
Figure 3 represents the cytotoxic response of HepG-2 cells to AgNP exposure determined by the 
MTT assay. In the presence of AgNP cell viability decreases in a dose and time dependent manner, 
with a substantial decline in mitochondrial integrity detected at concentrations of 15.6µg/ml and 
above. A significant decrease in cell survival occurs at concentrations of 15.6µg/ml after 48 hour 
exposure while a significant reduction in cell viability at all exposure time points occurs at AgNP 
concentrations of 31.25µg/ml and upwards. 
A DCF-DA plate assay was employed to detect any ROS production in response to AgNP exposure 
over a 24 hour period. Readings were taken every hour for 6 hours. Following this 
readings were then taken at 12 and 24 hours to detect any delayed intracellular ROS production in 
response to increasing concentrations of nanoparticle exposure. Figure 4 illustrates ROS 
generation in response to AgNP exposure. The study shows that the amount of ROS produced 
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increases with increasing length of nanoparticle exposure and also with increasing concentration. 
ROS production was noted at concentrations of 7.8µg/ml and above after 15 minutes exposure and 
was seen to increase with dose and exposure time. The greatest level of ROS production was 
observed at a concentration of 500µg/ml after 12 hours of exposure. A reading at 24 hours shows 
a decline in ROS production compared to the 12 hour time point which can be associated with cell 
death. Confocal microscopy was employed to confirm ROS induction due to AgNP exposure at a 
concentration of 31.25µg/ml in figure 5. 
 
Figures 6 and 7 show the toxic response of AgNP to HepG-2 cells, but in the presence of UDCA. 
The same dose dependent response was noted as with the previous assays, following exposure to 
AgNP alone with this response increasing over time. The MTT assay (figure 6) showed a 
significant decline in cell viability after 96 hours at a concentration of 7.81µg/ml.  At a 15.6µg/ml 
concentration of AgNP a significant decrease in viability is observed following 48, 72 and 96 hour 
exposures. It was only at concentrations of 31.25µg/ml and above that a significant reduction in 
cell survival is seen at all exposure time points. Interestingly the presence of UDCA appears to 
have had no effect on cellular response to AgNP exposure, with almost identical patterns of toxicity 
observed both with and without the addition of UDCA. This suggests that the presence of UDCA 
does not modify AgNP toxicity. 
 
In the presence of UDCA (figure 7) a similar pattern of ROS production was observed as with the 
AgNP exposure alone although it appears more erratic with larger error bars. The same dose and 
time dependent response was observed with ROS induction detected following 15 minute exposure 
at concentrations as low as 3.91µg/ml. A similar trend was observed with ROS induction in the 
presence of AgNP alone and a maximum ROS production was observed at a concentration of 
500µg/ml after 12 hour exposure. Following 24 hour exposure ROS production was seen to 
decline, again this can be attributed to cell death. ROS induction by a concentration of 31.25µg/ml 
AgNP was confirmed by confocal microscopy illustrated in figure 8. It is apparent from the data 
that UDCA does not alter oxidative stress induced by AgNP exposure and it can be concluded that 
UDCA does not mediate AgNp ability to induce intracellular ROS production. 
 
Figure 9 represents the exposure of HepG-2 cells to AgNP in the presence of cholic acid (CA). 
Again a dose and time dependent response to AgNP exposure was observed with this assay. A 
noted decline in cell viability can be seen after 24 hours of exposure at an AgNP concentration of 
3.91µg/ml and then an apparent increase in viability compared to the unexposed control after 
longer exposure periods at the same concentration, indicative of a possible cell recovery. At an 
AgNP concentration of 3.91µg/ml after a 24 hour exposure a significant decline in cell viability is 
apparent. At exposure times of 48 and 72 hours a significant decline in viability was also observed 
when compared to the unexposed control. At 15.6µg/ml and above significant reduction in cell 
survival could be seen at all exposure concentrations when compared to the unexposed negative 
control. As observed with UDCA, the addition of CA does not appear to modify the toxicity of 
AgNP and the response in the presence of CA is seemingly identical, with no significant difference 




Further studies were performed with the DCF-DA plate assay to determine the ability of AgNP 
with addition of CA to induce oxidative stress. Figure 10 demonstrates ROS production in a dose 
and time dependent manner. Generation of ROS is seen at the higher concentrations of AgNP 125, 
250 and 500µg/ml. Induction of intracellular ROS was noted after 15 minutes of exposure 
compared to the unexposed control with the highest generation detected after this time and at the 
highest AgNP concentration 500µg/ml. After 15 minutes of exposure ROS production begins to 
decline in a step-wise pattern as exposure time progresses with no ROS detected after the 4 hour 
exposure point. In comparison to HepG-2 exposure to AgNP alone, the addition of CA alters the 
pattern of ROS production. In the presence of CA, ROS induction occurs almost immediately after 
exposure to AgNP and then declines rapidly compared to earlier time points with no ROS detected 
after 4 hours. Induction of ROS only occurs at the higher exposure concentrations 125, 250 and 
500µg/ml. Exposure to AgNP alone results in a much lower percentage of ROS induction 
compared to the unexposed control that increases over time and only begins to decline after 12 
hours of exposure. In the presence of CA induction of ROS occurs much quicker but declines at a 
similar rate whereas in the presence of AgNP only ROS production is more sustained over time. 
Conformation of ROS induction by AgNP at a concentration of 3.91µg/ml in the presence of 1mM 
CA was verified by confocal microscopy as illustrated in figure 11. 
Figure 12 illustrates the toxic response of HepG-2 cells to AgNP exposure in the presence of 
deoxycholic acid (DCA). As can be seen in figure 9 a loss in mitochondrial integrity is 
demonstrated at the lowest AgNP concentration of 3.91µg/ml at all exposure time points. 
Significant loss is seen at a concentration 3.91µg/ml after 24 hour exposure. There is significant 
reduction at this concentration after 72 and 96 hour incubations but not after 48 hour incubation 
again this may be due to cell recovery. As the AgNP are in low doses it is possible they have fallen 
out of solution at this time and any effect was induced within the first 6-12 hours following 
exposure. After this point any surviving cells may be starting to recover and replicate. The same 
pattern is observed at a concentration of 7.81µg/ml. A significant reduction is observed at all 
exposure time points from a concentration of 15.6µg/ml and above. 
 
The induction of ROS upon exposure to AgNP with the addition of DCA (figure 13) follows a 
similar pattern to that observed with the addition of CA. However it can be seen that ROS are 
induced at much lower concentrations of AgNP when compared to the CA and in the presence of 
AgNP alone. ROS were detected after 15 minutes at a concentration of 31.25µg/ml and higher 
with maximum ROS production occurring at 500µg/ml after a 15 minute exposure. After 15 
minutes ROS levels begin to decline with increasing exposure time. When compared to exposure 
of HepG-2 cell to AgNP alone the observed ROS induction occurs at lower concentrations of 
AgNP and does not increase with time but begins to decline after 15 minutes. Indeed to the case 
of CA, where ROS induction occurs much earlier but is short lived. It appears that AgNP exposure 
in the presence of DCA results in the greatest ROS induction compared to the unexposed control 
and at lower doses when compared to the AgNP exposure with CA and AgNP exposure alone. 
Confirmation of ROS induction by AgNP at a concentration of 3.91µg/ml in the presence of 




The AB assay was also performed for the HepG-2 cell line in the presence and absence of UDCA, 
CA and DCA where a dose and time dependent response was also observed resulting from AgNP 
exposure. AB gives a more general picture of the loss in cell viability by targeting the cytosol of 
the cell and detecting a change in the cytosolic environment. A similar pattern of toxicity was 
observed with the addition of DCA having a substantial effect on cell viability occurring after 24 
hours of exposure (data not shown). 
Statistical analysis (p<0.05) comparing the differences in toxicity induced by AgNP alone and in 
the presence of the tested biofluid components highlighted statistically significant differences 
between the toxicological data. The presence of CA and DCA significantly altered the cytotoxic 
effect induced by AgNP on HepG-2 cells at a concentration of 15.6µg/ml and above the response 
curves were found to be statistically (p<0.05) different. This change was noted at 48, 72 and 96 




Cytotoxic evaluation of Hep2 cell line to AgNP exposure alone and in the presence of UDCA  
As a control, another cell line was tested to establish if biofluid components could modify the 
effects of AgNP exposure in areas other than their target organs. To investigate this, the Hep2 cell 
line was selected. The same exposure concentrations were employed and the effects of AgNP 
toxicity in the presence of biofluid components were investigated. UDCA was chosen as the test 
bile acid. A dose finding experiment was performed to determine the highest concentration of 
UDCA that the Hep2 cell line could withstand without causing toxicity. This concentration was 
found to be 2.2 x 10-7 M and this is the working concentration that was employed for the following 
experiments. 
Figure 15 displays the cytotoxic response of Hep2 cells to AgNP exposure determined by the MTT 
assay. This assay demonstrates a typical dose and time dependent pattern with significant reduction 
in cell survival is seen at all concentrations following 72 hour exposure. A significant reduction in 
viability after 72 and 96 hours was observed at doses of 7.81µg/ml and above and after 48 hours 
at a concentration of 31.25µg/ml and above. Furthermore a significant decrease in cell survival 
compared to the unexposed control was observed for all exposure time points at a concentration 
of 62.5µg/ml and above. 
 
Figure 16 illustrates the toxic response of AgNP to Hep2 cells in the presence of UDCA. The data 
demonstrate that in the presence of UDCA there is a dramatic reduction in cell viability compared 
to when cells are exposed to AgNP alone. No significant change in cell viability occurs after 24 
hour exposure but a significant reduction following 48, 72 and 96 hour exposures was noted at all 
tested concentrations of AgNP. The data presented illustrates that compared to AgNP exposure 




A DCF-DA plate assay was also employed to investigate intracellular oxidative stress, to see if the 
presence of UDCA could influence the generation of ROS in response to AgNP exposure. 
Exposure to increasing concentrations of AgNP induced ROS production in a dose and time 
dependent manner (figure 17). ROS production was detected at exposure concentrations of 
7.81µg/ml and above with maximum production seen at 500µg/ml. Induction of ROS was 
observed after 15 minutes of exposure with maximum production observed after 1 hour after which 
levels of detectable ROS began to decline. In the presence of UDCA (figure 18) a substantial 
reduction in ROS generation was observed when compared to exposure to AgNP alone and ROS 
were only detected at higher concentrations of AgNP above 250µg/ml. A maximum level ROS 
production with added UDCA was observed at a concentration of 500µg/ml after 1 hour and as 
illustrated by the data the percentage of ROS induction when compared to the negative control is 
substantially reduced compared to the amount generated in the absence of UDCA.  
The AB assay was also performed for the Hep2 cell line in the presence and absence of UDCA 
where a dose and time dependant response was also observed resulting from AgNP exposure. A 
similar pattern of toxicity was observed with the addition of UDCA having a substantial effect on 
cell viability occurring after 24 hours of exposure (data not shown). 
Statistical analysis (p<0.05) comparing the differences in toxicity induced by AgNP alone and in 
the presence of UDCA in Hep2 cells highlighted statistically significant differences between the 
toxicological data. A significant effect on toxicity was noted in the presence of UDCA from the 
lowest test concentration up to 250µg/ml after 48 and 96 hour time points compared with exposure 




It is clear from the literature that exposure to nanoparticles is becoming more widespread mainly 
due to their continued incorporation into various consumer products. Upon exposure, nanoparticle 
contact with surfactants and biofluids is inevitable and it is important to take these events into 
account when examining toxicity. This study aimed to investigate this interaction to identify a 
possible modification of toxicity by individual components of one of the major biofluids within 
the body. 
The physiochemical characteristics of AgNP play an important role in how they will interact with 
biological systems. The size, associated surface area, shape and chemical composition have all 
been shown to be of great importance to nanoparticle toxicity. Size influences surface area which 
leads to greater cell contact, while truncated triangular nanoparticles show increased toxicity 
compared to spherical nanoparticles and it is believed that cylindrical particles can cross the cell 
membrane easier than other shapes due to their ability to harness the clatherin machinery (Renwick 
et al, 2004; Rai et al, 2009; Kam et al, 2004).  
It is now well established that upon entry into the body nanoparticles almost immediately become 
coated in protein and that this adsorbed layer or “corona” is important in biological responses to 
nanoparticle exposure (Gray, 2004; Lynch & Dawson, 2008). While there will be adsorption of 
the proteins of biofluid components and cell culture media onto the nanoparticle surface, it can be 
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assumed that these proteins will associate and dissociate from AgNP at different rates depending 
on a factors such as concentration and affinity (Lynch et al, 2007).    
Proteins tend to agglomerate upon dispersion in an aqueous solution and may coat AgNP trapping 
them within agglomerates increasing the rate at which they fall out of solution. A number of studies 
have investigated this dispersion to determine how this affects overall toxicity. It is known that 
nanoparticles once suspended in cell culture media can precipitate out of solution and agglomerate 
at different rates. As such this raises a number of questions relating to dosimetry and the effect of 
agglomerate formation on the end result of nanoparticle exposure.  As well as influencing the 
results of toxicity it can also influence exposure times as agglomerate formation and precipitation 
may increase the time taken for delivery of the full dose to cells. Further investigation is required 
to develop a method of including dosimetric parameters into toxicological testing so that accurate 
results for in vitro assays can be obtained that are comparable to animal models (Cohen et al, 2014; 
Cohen et al, 2013; Kroll et al, 2009; Teeguarden et al, 2007).   
Zeta potential analysis was also performed and a change in values would indicate interaction of 
nanoparticles with biofluid components and cell culture media, suggesting indirect toxicity caused 
by their interaction (Casey et al, 2007; Casey et al, 2008). No change on overall stability was noted 
following biofluid component addition. The overall particle stability also influences size and 
agglomerative state. Larger unstable zeta potential values were noted for AgNP dispersions in 
media with biofluid component addition. These large values suggest particles will repel each other 
reducing the potential to agglomerate. The dispersant plays a role in particle stability thus effecting 
size and possible agglomeration (Xia et al, 2006). 
A recent study demonstrated that AgNP exposed to synthetic stomach fluid led to transformations 
in the particles including particle aggregation, changes in particle morphology and the release of 
silver ions (Mwilu et al, 2013).  It was suggested that alterations to AgNP size and surface 
properties due to exposure to synthetic stomach acid may impact on their transformation through 
the gastrointestinal tract and may in turn influence AgNP interaction with the cells they encounter. 
The binding of proteins be it from cell culture media or biofluid components can aid in the binding 
of particles to cell surfaces, their trafficking through biological systems and the resulting effects 
will also be altered. Very recently in a study by Wang et al (2013), the protein surface coating or 
“corona” was identified as providing a Trojan horse effect to nanoparticles. Initial entry of 
nanoparticles into the cell did not cause immediate toxicity, it was only when the nanoparticles 
were transported to the lysosome and the corona was degraded in the acidic environment that 
toxicity was observed. At this point, much later after initial exposure, loss of lysosomal integrity 
and release of its contents was observed followed by cell death via apoptosis (Wang et al, 2013). 
These findings can be related to the work undertaken in this study as biofluid components are 
protein entities and will ultimately form part of the protein corona and may contribute to particle 
interactions with living systems and any related toxicity. 
This reiterates the importance of performing realistic exposure scenarios in toxicological testing 
to determine nanoparticles interactions in biological systems. These results highlight the 
importance of establishing the physiochemical characteristics of AgNP in a variety of biological 
suspensions as their interactions with these components influence their interactions with cellular 
components and biological systems and will ultimately determine their distribution throughout the 
body and the signalling pathways and end responses they induce. 
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The cytotoxicity studies undertaken illustrate that mitochondrial integrity (MTT) and the general 
health of the cell (AB) is affected by exposure to AgNP and that the chosen biofluid components 
have different modifying effects. Table 2 concisely illustrates IC50 values for both assays providing 
an overall synopsis of toxicity. From the data presented it can be suggested CA and DCA do have 
some modifying effects. While not altering the pattern of toxicity in the viability assays, the pattern 
of ROS induction is altered upon their addition. The addition of CA and DCA induces greater 
levels of ROS induction with DCA producing the greatest response following a 15 minute 
exposure at the highest concentration of AgNP compared to the unexposed control. AgNP 
exposure alone produces much lower levels of ROS with maximum values only slight higher 
compared to the unexposed control. This increase in ROS production and at earlier points of 
exposure may suggest a more rapid or alternative pathway of cell death in the presence of CA and 
DCA. Previous studies have shown that lipid peroxidation by nanomaterials is a contributing factor 
to the generation of ROS and the overwhelming of natural antioxidant systems. ZnO is noted as 
enhancing lipid peroxidation contributing to increased ROS generation while AgNP exposure in 
rats can cause increased lipid peroxidation and quench naturally occurring antioxidants. It is 
postulated that the increased levels of ROS following AgNP-CA and AgNP-DCA exposure 
enhances lipid peroxidation within cells resulting in the greater levels of ROS noted compared to 
AgNP exposure alone (Premanathan et al, 2011; Adeyemi & Faniyan, 2014). This upsurge in 
generation may be the result of a reactive product formed by the interaction of AgNP and biofluid 
components. Further investigation into the mechanism of cell death and the potential role of lipid 
peroxidation within cells must be investigated.  
While no modification in toxicity by UDCA was noted in the HepG-2 cell line, modification was 
noted in Hep2 cells. A delay in toxicity in the first 24 hours after exposure together with a reduction 
in ROS production strongly suggests that UDCA can modify Hep2 toxic response to AgNP 
exposure. While it appears to increase AgNP toxicity, ROS induction is significantly reduced 
suggestive of an antioxidant effect. This may indicate an alternative mechanism of cell death. 
These data indicate that UDCA can modify AgNP toxicity in a cell type different from that of its 
normal target. 
While it is clear AgNP cause toxicity, it must be considered how much of this toxicity is attributed 
to the release of silver ions. A recent study by Beer et al (2012) addressed this phenomenon, 
identifying to what level the fraction of silver ions in various AgNP suspensions (commercially 
available and laboratory synthesized) influence toxicity (Beer et al, 2012). The study concluded 
that free silver ions in AgNP preparations do indeed play a considerable role in the overall toxicity 
of AgNP suspensions. However other studies are in agreement that at lower concentrations of 
metal ions, the uptake of nanoparticles leads to additional toxicity compared to higher 
concentrations where it appears the particles do not contribute to further toxicity (Navarro et al, 
2008; Kim et al, 2009). Beer et al (2012) postulate that the mechanism of toxicity for AgNP is 
dissolution of particles in lysosomes, previously observed for copper oxide (CuONP) 
nanoparticles, possibly due to a protective barrier effect of the plasma membrane but this barrier 
can be evaded by a Trojan horse mechanism when nanoparticles are taken up by cells (Studer et 
al, 2010; Limbach et al, 2007). It must also be considered that sonication of AgNP suspensions 
and other preparation methods may have contributed to silver ion release and therefore toxicity. 
For example during sonication the energy released in order to break up large AgNP aggregates is 
converted to thermal energy which may promote dissolution of silver ions from particles (Liu & 
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Hurt, 2010).  From this information it is clear that when investigating AgNP toxicity, the role of 
both silver ions and the particles themselves must be considered. 
In order to monitor the potential mediation of the chosen biofluid components on AgNP toxicity 
in cells found outside of their normal target area, an epithelial laryngeal cell line was chosen. The 
biofluid components under study have been employed as pharmaceutical agents and medications. 
UDCA is widely used as a method of gallstone dissolution (Arisawa et al, 2009; Lapenna et al, 
2002). This treatment has numerous trade names, including Actigall™ and BILIVER™, and is an 
oral treatment presented as an alternative to surgery. Cholic acid and deoxycholic acid also have 
medical applications. Cholic acid is used as treatment for children and adults with inborn errors in 
bile acid synthesis. Orphacol™ as it is known is taken orally and is vital in preventing the 
development of cholestatic liver disease (European Medicines Agency, 2013). Deoxycholic acid 
also has uses as a therapeutic drug used to treat localized fat deposits via subcutaneous injection. 
Studies have also reported the conjugation of heparin to deoxycholic acid in order to develop an 
oral delivery system for anticoagulant treatment preferable to the standard intravenous and 
subcutaneous injection (Lee et al, 2001; Kim & Vaishali, 2006). The fact that these bile acids are 
or may be utilized in a medicinal capacity highlights that they will be present in areas of the body 
other than the liver. As such the data presented here on a laryngeal cell line is a relevant line of 
investigation given that in most cases these bile acid derived treatments are given orally. As the 
data demonstrate, the effect on toxicity in cell lines of different origins must be seriously 




The data demonstrate that biofluid components can significantly influence the toxic profile of 
AgNP. As such future studies must consider the effects various biofluids and their components 
have on the processing of nanoparticles upon entry to the body, their presentation to cells, 
distribution and the biological processes they induce. Finally researchers must not just consider 
the toxicity of the isolated nanoparticles but that of a combined effect including, the local 
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Table 1 Table of Zeta Potential results for three concentrations of AgNps 3.91, 15.6 and 62.5µg/ml 
dispersed in different cell culture media and in the presence of different biofluid components. Data 
expressed as average value ±SD of three individual experiments. 
 
 
62.5µg/ml 15.6µg/ml 3.9µg/ml 
AgNP Only -15.5 ±1.2mV -31.2 ± 0.9mV -22.1 ± 6.6mV 






AgNP DMEM -7.9  ± 5.1mV 1.9 ± 3.4mV -11.2 ± 7.2mV 
AgNP 1mM Cholic Acid DMEM -7.1 ± 6.9mV -2.56 ± 3.4mV -27.6 ± 5mV 
AgNP 0.125mM  Deoxycholic Acid 
DMEM 
-4.9 ± 9.8mV -12.1 ± 5mV -5.5 ± 8.9mV 


















Table 2 Calculated IC50 values (µg/ml) resulting from exposure to AgNps for the AB and MTT 
assays in the HepG-2 and Hep2 cell lines. * Denotes lethal dose less than the lowest exposure 
concentration. IC50 values were calculated from the average response of three independent 
experiments fitted to a sigmoidal curve and a four parameter logistic model used to calculate 
Inhibitory Concentration (IC50) with a (p<0.05) 
Cell Line AB assay IC50 (µg/ml) MTT assay IC50 (µg/ml) 
 24hr 48hr 72hr 96hr 24hr 48hr 72hr 96hr 
HepG-2 5.5 7.8 5.5 4.2 119.51 45.34 44.59 49.2 
HepG-2 + UDCA 6.3 9.1 5.3 5.7 135.06 66.52 31.81 10.97 
HepG-2 + CA 4.03 6.24 4.78 7.94 0.0004 0.0003 0.001 215.48 
HepG-2 + DCA 4.28 6.49 2.99 6.24 1389.3 746.29 0.002 0.003 
Hep2 45.06 31.58 8.8 91.9 388.39 157 2.19 43.41 














Figure 1 SEM micrograph at scale bar of 2µm image pristine AgNP dispersed in ethanol to a 

































































































































Figure 2 (a) – (d) Dynamic Light Scattering size (nm) particle number (count) distribution plot of 
AgNP (15.6µg/ml) dispersed in media, dH2O and in the presence of (a) UDCA (RPMI), (b) UDCA 
(DMEM), (c) CA and (d) DCA. Data presented is the average of three individual experiments 
 
 
Figure 3 Cytotoxicity of AgNP in HepG-2 cells after 24, 48, 72, and 96hr exposures as determined 
by the MTT assay. Data expressed as percentage of control mean ± SD of three individual 
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Figure 4 ROS generation in HepG-2 cells after different time points of AgNP exposure. Data 
expressed as percentage of control mean ± SD of eight independent experiments.  
 
 
Figure 5 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in cell culture 
media. Image taken on a Zeiss 510 LSM confocal microscope with an argon ion laser, excitation 
488nm using a band pass filter 505-530nm to detect DCF. (a) LSM image demonstrating 













































Figure 6 Cytotoxicity of AgNP in HepG-2 cells with added UDCA after 24, 48, 72 and 96hr 
exposures as determined by the MTT assay. Data expressed as percentage of control mean ± SD 
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Figure 7 ROS generation in HepG-2 cells after different time points of AgNP exposure in the 
presence of UDCA. Data expressed as percentage of control mean ± SD of eight independent 
experiments.  
 
Figure 8 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in cell culture 
media in the presence of UDCA. Image taken on a Zeiss 510 LSM confocal microscope with an 
argon ion laser, excitation 488nm using a band pass filter 505-530nm to detect DCF. (a) LSM 
image demonstrating intracellular ROS, (b) overlay of LSM and brightfield image. 
 
 
Figure 9 Cytotoxicity of AgNP in HepG-2 cells with added CA after 24, 48, 72, and 96hr 
exposures as determined by the MTT assay. Data expressed as percentage of control mean ± SD 
of three independent experiments. * denotes a statistically significant (p<0.01) difference from 
the unexposed control 
*
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Figure 10 ROS generation in HepG-2 cells after different time points of AgNP exposure in the 




Figure 11 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in cell culture 
media in the presence of CA. Image taken on a Zeiss 510 LSM confocal microscope with an argon 
ion laser, excitation 488nm using a band pass filter 505-530nm to detect DCF. (a) LSM image 















































Figure 12 Cytotoxicity of AgNP in HepG-2 cells with added DCA after 24, 48, 72, and 96hr 
exposures as determined by the MTT assay. Data expressed as percentage of control mean ± SD 






















































































Figure 13 ROS generation in HepG-2 cells after different time points of AgNP exposure in the 
presence of DCA. Data expressed as percentage of control mean ± SD of eight independent 
experiments.   
 
Figure 14 Confocal image (x40) of cells exposed to 31.25µg/ml AgNP suspended in cell culture 
media in the presence of DCA. Image taken on a Zeiss 510 LSM confocal microscope with an 
argon ion laser, excitation 488nm using a band pass filter 505-530nm to detect DCF. (a) LSM 
image demonstrating intracellular ROS, (b) overlay of LSM and brightfield image. 
 
 
Figure 15 Cytotoxicity of AgNP to Hep2 cells after 24, 48, 72 and 96hr exposure as determined 
by the MTT assay. Data expressed as percentage of control mean ± SD of three independent 

























































Figure 16 Cytotoxicity of AgNP to Hep2 cells with added UDCA after 24, 48, 72 and 96hr 
exposures as determined by the MTT assay. Data expressed as percentage of control mean ± SD 




Figure 17 ROS generation in Hep2 cells after different time points of AgNP exposure. Data 
expressed as percentage of control mean ± SD of eight independent experiments 
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Figure 18 ROS generation in Hep2 cells after different time points of AgNP exposure in the 
presence of UDCA. Data expressed as percentage of control mean ± SD of eight independent 
experiments 
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